| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000254756.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.04656519 |
Resistant |
| ENSG00000254756.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.016734381 |
Sensitive |
| ENSG00000254756.1 |
Avagacestat |
Breast invasive carcinoma |
0.023562302 |
Sensitive |
